ConductScience.org, home

Paper37081981

Investigating miR-9 as a mediator in laryngeal cancer health disparities.

Gobin C and 14 others. Front Oncol, 2023. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Investigating miR-9 as a mediator in laryngeal cancer health disparities. Papers, record 37081981. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37081981

Download JSON
Cell line
UM-SCC-10A20 papers
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Investigating miR-9 as a mediator in laryngeal cancer health disparities.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.53
iCite
Revised in PubMed
2023-12-01
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gobin CChristina
2Inkabi SSamuel
3Lattimore CCChayil C
4Gu TTongjun
5Menefee JNJames N
6Rodriguez MMayrangela
7Kates HHeather
8Fields CChristopher
9Bian TTengfei
10Silver NNatalie
11Xing CChengguo
12Yates CClayton
13Renne RRolf
14Xie MMingyi
15Fredenburg KMKristianna M

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08 DE029503NIDCR NIH HHSUnited StatesK08DE029503PubMed and NIHNIH RePORTER
P01 CA214091NCI NIH HHSUnited StatesP01CA214091PubMed and NIHNIH RePORTER

Download CSV of grants

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130002503Comprehensive analysis of competitive endogenous RNAs network associated with head and neck squamous cell carcinoma.Sci Rep2018https://conductscience.org/library/papers/30002503PubMed
234871535Identification of key miRNA signature and pathways involved in multiple myeloma by integrated bioinformatics analysis.Hematology2021https://conductscience.org/library/papers/34871535PubMed
321911355miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades.Nucleic Acids Res2012https://conductscience.org/library/papers/21911355PubMed
415609302Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database.Int J Cancer2005https://conductscience.org/library/papers/15609302PubMed
522133638Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas.Oral Oncol2012https://conductscience.org/library/papers/22133638PubMed
632182788Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis.Cancers (Basel)2020https://conductscience.org/library/papers/32182788PubMed
719910308edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.Bioinformatics2010https://conductscience.org/library/papers/19910308PubMed
829073835miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.Artif Cells Nanomed Biotechnol2018https://conductscience.org/library/papers/29073835PubMed
934158050Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in laryngeal squamous cell cancer.Cancer Cell Int2021https://conductscience.org/library/papers/34158050PubMed
1024670052Importance of ABCC1 for cancer therapy and prognosis.Drug Metab Rev2014https://conductscience.org/library/papers/24670052PubMed
1120967872Determinants of head and neck cancer survival by race.Head Neck2011https://conductscience.org/library/papers/20967872PubMed
1226844274A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.EBioMedicine2015https://conductscience.org/library/papers/26844274PubMed
1334315420A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer.BMC Cancer2021https://conductscience.org/library/papers/34315420PubMed
1430423142miRBase: from microRNA sequences to function.Nucleic Acids Res2019https://conductscience.org/library/papers/30423142PubMed
1533799314Association of race and health care system with disease stage and survival in veterans with larynx cancer.Cancer2021https://conductscience.org/library/papers/33799314PubMed
1618187804MicroRNAs modulate the chemosensitivity of tumor cells.Mol Cancer Ther2008https://conductscience.org/library/papers/18187804PubMed
1714973191Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/14973191PubMed
1823399519Biological determinants of health disparities in prostate cancer.Curr Opin Oncol2013https://conductscience.org/library/papers/23399519PubMed
1927664388Treatment delays, race, and outcomes in head and neck cancer.Cancer Epidemiol2016https://conductscience.org/library/papers/27664388PubMed
2024062209Genetic variants in microRNAs and breast cancer risk in African American and European American women.Breast Cancer Res Treat2013https://conductscience.org/library/papers/24062209PubMed

See all 66 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
40998459MicroRNAs and Cancer Racial Disparities.Wiley Interdiscip Rev RNA2025https://conductscience.org/library/papers/40998459PubMed
40721473Arsenic trioxide regulates DYNAP through hsa-mir-573 and inhibits the proliferation of laryngeal cancer.Sci Rep2025https://conductscience.org/library/papers/40721473PubMed
39476205miR-128-3p suppresses tumor growth and enhances chemosensitivity in tongue squamous cell carcinoma through MAP2K7 targeting.Mol Biol Rep2024https://conductscience.org/library/papers/39476205PubMed
37587481MicroRNAs as the pivotal regulators of cisplatin resistance in head and neck cancers.Cancer Cell Int2023https://conductscience.org/library/papers/37587481PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37081981

GET https://conductscience.org/api/papers/v1/37081981/references?page=2